Recursion Pharmaceuticals (RXRX) Receivables (2020 - 2022)
Recursion Pharmaceuticals posted quarterly Receivables of $2.8 million for Q4 2022, down 69.71% year-on-year from $9.1 million in Q4 2021, and down 76.34% on a QoQ basis from $11.6 million in Q3 2022.
Recursion Pharmaceuticals (RXRX) has 3 years of Receivables data on file, last reported at $2.8 million in Q4 2022.
- For the quarter ending Q4 2022, Receivables fell 69.71% year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2022 stood at $2.8 million (down 69.71% YoY), and the FY2022 full-year result was $2.8 million, down 69.71% from the prior year.
- Receivables for Q4 2022 stood at $2.8 million, down from $11.6 million in the prior quarter.
- Across five years, Receivables topped out at $11.7 million in Q2 2022 and bottomed at $49000.0 in Q2 2021.
- The 3-year median for Receivables is $2.8 million (2022), against an average of $5.5 million.
- Peak annual rise in Receivables reached 23736.73% in 2022, while the deepest fall reached 69.71% in 2022.
- A 3-year view of Receivables shows it stood at $156000.0 in 2020, then jumped by 5726.92% to $9.1 million in 2021, then plunged by 69.71% to $2.8 million in 2022.
- The last three Receivables figures came in at $2.8 million (Q4 2022), $11.6 million (Q3 2022), and $11.7 million (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 4.15 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.73 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 883.96 Mn |
| 10 | Recursion Pharmaceuticals | 2.01 Bn | 1.35 Bn | -6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | 11.64 Mn |
| Jun 30, 2022 | 11.68 Mn |
| Mar 31, 2022 | 11.40 Mn |
| Dec 31, 2021 | 9.09 Mn |
| Sep 30, 2021 | 2.28 Mn |
| Jun 30, 2021 | 49,000.00 |
| Mar 31, 2021 | 71,000.00 |
| Dec 31, 2020 | 156,000.00 |